Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.

European respiratory review : an official journal of the European Respiratory Society - 30 Sept 2017

Torre Olga, Elia Davide, Caminati Antonella, Harari Sergio

Abstract excerpt

Lymphangioleiomyomatosis (LAM) and pulmonary Langerhans cell histiocytosis (PLCH) are rare diseases that lead to progressive cystic destruction of the lungs. Despite their distinctive characteristics, these diseases share several features. Patients affected by LAM or PLCH have similar radiological cystic patterns, a similar age of onset, and the possibility of extrapulmonary involvement. In this review, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Histiocytosis, Langerhans-Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Proto-Oncogene Proteins B-raf

Share to Respiratory Function Tests

Share to Tomography, X-Ray Computed

Share to TOR Serine-Threonine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 28954765
DOI: 10.1183/16000617.0042-2017
PMCID: PMC9488980

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.PMID 28954765Read ↗

Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.Semantic proximity Read ↗

Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.Semantic proximity Read ↗

Langerhans cell histiocytosis: current advances in molecular pathogenesis.Semantic proximity Read ↗

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.Semantic proximity Read ↗

Pulmonary Langerhans Cell Histiocytosis.Semantic proximity Read ↗

Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice.Semantic proximity Read ↗

Langerhans Cell Histiocytosis: A Clinicopathologic Review and Molecular Pathogenetic Update.Semantic proximity Read ↗

Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.Semantic proximity Read ↗

Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatmentSemantic proximity Read ↗

Erdheim-Chester disease: a rapidly evolving disease model.Semantic proximity Read ↗

Recent advances in the management of lymphangioleiomyomatosisSemantic proximity Read ↗

[Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.